uveal melanoma
Showing 26 - 50 of 81
Frequency and Clinical Phenotype of BAP1 Hereditary
Recruiting
- Uveal Melanoma
- +7 more
-
Columbus, OhioThe Ohio State University Wexner Medical Center
Jul 6, 2022
Uveal Melanoma Trial in Worldwide
Recruiting
- Uveal Melanoma
-
Boston, Massachusetts
- +14 more
Jun 28, 2022
Prospective Registration Of Patient Data and Quality of Life in
Recruiting
- Uveal Melanoma
- Quality of life questionnaires
- +3 more
-
Leiden, Zuid-Holland, NetherlandsLeiden University Medical Center
May 11, 2022
Uveal Melanoma, Liver Metastases Trial in Gothenburg (Isolated hepatic perfusion, Ipilimumab, Nivolumab)
Recruiting
- Uveal Melanoma
- Liver Metastases
- Isolated hepatic perfusion
- +2 more
-
Gothenburg, SwedenSahlgrenska University Hospital
May 3, 2022
Uveal Melanoma Trial in Scottsdale (Novocure Optune, Opdivo, Yervoy)
Recruiting
- Uveal Melanoma
- Novocure Optune
- +2 more
-
Scottsdale, ArizonaHonorHealth Research Institute
Mar 21, 2022
Uveal Melanoma Trial in Spain (ipilimumab, Nivolumab)
Completed
- Uveal Melanoma
-
Palma De Mallorca, Baleares, Spain
- +9 more
Mar 8, 2022
Uveal Melanoma Trial in Worldwide (IMCgp100, Dacarbazine, Ipilimumab)
Active, not recruiting
- Uveal Melanoma
- IMCgp100
- +3 more
-
Los Angeles, California
- +55 more
Mar 10, 2022
Uveal Melanoma Trial in Worldwide (IMCgp100)
Active, not recruiting
- Uveal Melanoma
-
La Jolla, California
- +25 more
Mar 10, 2022
Uveal Melanoma, Ocular Melanoma, Choroidal Melanoma Trial in United States (Light-activated AU-011, Laser Activation)
Completed
- Uveal Melanoma
- +2 more
- Light-activated AU-011
- Laser Activation
-
Tucson, Arizona
- +12 more
Jan 12, 2022
Vascular Response to Brachytherapy Using Functional OCT
Active, not recruiting
- Uveal Melanoma
-
Portland, OregonOHSU Knight Cancer Institute
Jan 7, 2022
Uveal Melanoma Trial in New York (ADI PEG20, Nivolumab, Ipilimumab)
Active, not recruiting
- Uveal Melanoma
- ADI PEG20
- +2 more
-
New York, New YorkMemorial Sloan - Kettering Cancer Center
Jan 10, 2022
Genetic Mutations and of Circulating mRNAs in Uveal Melanoma
Recruiting
- Uveal Melanoma
- blood sample examination
-
Catania, Italy
- +2 more
Dec 20, 2021
Efficiency and Safety of ICIs in Different Malignancies
Recruiting
- Melanoma
- +3 more
- Genetic tests of the available tumor and plasma samples
-
Moscow', Москва, Russian FederationN.N. Blokhin Russian Cancer Research Center
Dec 26, 2021
Uveal Melanoma Trial in Boston (BVD-523)
Active, not recruiting
- Uveal Melanoma
-
Boston, Massachusetts
- +1 more
Nov 19, 2021
Relapsed Neuroblastoma, Refractory Neuroblastoma, Relapsed Osteosarcoma Trial in Houston (C7R-GD2.CART cells, Cyclophosphamide,
Recruiting
- Relapsed Neuroblastoma
- +6 more
- C7R-GD2.CART cells
- +2 more
-
Houston, Texas
- +1 more
Nov 12, 2021
Uveal Melanoma Trial in Berlin (SIRT, DSM-TACE)
Recruiting
- Uveal Melanoma
- SIRT
- DSM-TACE
-
Berlin, GermanyCharité - University Medicine Berlin, Dept. of Haematology, Medi
Nov 8, 2021
Uveal Melanoma Trial in Philadelphia (Stereotactic Body Radiation Therapy, Ziv-Aflibercept)
Recruiting
- Uveal Melanoma
- Stereotactic Body Radiation Therapy
- Ziv-Aflibercept
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Aug 13, 2021
Uveal Melanoma, Hepatic Metastases Trial in San Francisco, Chicago, Philadelphia (SIR-Spheres® Yttrium 90, ipilimumab,
Active, not recruiting
- Uveal Melanoma
- Hepatic Metastases
- SIR-Spheres® Yttrium 90
- +2 more
-
San Francisco, California
- +2 more
Apr 15, 2021
Uveal Melanoma Trial in Paris (Blood test)
Recruiting
- Uveal Melanoma
- Blood test
-
Paris, FranceInstitut Curie
Jan 8, 2021